Table 3.
Recurrence rates by treatment modality.
| No recurrence (N = 37) |
Recurrence (N = 52) |
p-Value | |
|---|---|---|---|
| Primary surgery (n = 74): | 28 (37.8%) | 46 (62.2%) | NS |
| Wide local excision (n = 55) | 19 (34.5%) | 36 (65.5%) | |
| Radical vulvectomy (n = 13) | 7 (53.8%) | 6 (46.2%) | |
| Skinning vulvectomy (n = 4) | 2 (50.0%) | 2 (50.0%) | |
| Mohs surgery (n = 2) | 0 (0.0%) | 2 (100.0%) | |
| Margin status (n = 74): | NS | ||
| Positive margins (n = 47) | 21 (44.7%) | 26 (55.3%) | |
| Negative margins (n = 7) | 3 (42.9%) | 4 (57.1%) | |
| Unknown margin status (n = 20) | 4 (20.0%) | 16 (80.0%) | |
| Topical therapy (n = 5): | 1 (20.0%) | 4 (80.0%) | NS |
| Imiquimod (n = 4) | 1 (25.0%) | 3 (75.0%) | |
| 5-Fluorouracil (n = 1) | 0 (0.0%) | 1 (100.0%) | |
| Laser ablation (n = 1) | 0 (0.0%) | 1 (100.0%) | NS |
| Unknown (n = 9) | 8 (88.9%) | 1 (11.1%) | NS |